Antibodies Elicited by the 2025–2026 Influenza Vaccine
NEJM Evidence · 2026-03-24 · 5 (4)
DOI: 10.1056/evidpha2600007 ↗At a glance
Journal article in NEJM Evidence, published on 2026-03-24. Written by Jiaojiao Liu and 7 co-authors. Institution: Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Major MEDLINE topics: Antibodies, Viral, Influenza A Virus, H3N2 Subtype, Influenza Vaccines, Influenza, Human. Cited 10 times so far (Crossref); 4 references.
Abstract (original language)
AbstractA new H3N2 variant (named subclade K) possesses several key hemagglutinin substitutions and is circulating widely during the 2025-2026 influenza season. We sought to determine whether the 2025-2026 seasonal influenza vaccine elicits antibodies in humans that recognize this variant. We found that H3N2 subclade K viruses are antigenically advanced; however, the 2025-2026 seasonal influenza vaccine elicited antibodies in many individuals that efficiently recognized these viruses. Thus, the current seasonal influenza vaccine likely will be partially effective at preventing illness associated with H3N2 subclade K virus infections.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Cite
APA
Liu, J., Li, S. H., Ye, N., Griffiths, T., Drapeau, E. M., Atkinson, R. K., Collman, R. G., & Hensley, S. E. (2026). Antibodies Elicited by the 2025–2026 Influenza Vaccine. NEJM Evidence, 5(4). https://doi.org/10.1056/evidpha2600007
Vancouver
Liu J, Li SH, Ye N, Griffiths T, Drapeau EM, Atkinson RK, et al. Antibodies Elicited by the 2025–2026 Influenza Vaccine. NEJM Evidence. 2026;5(4). doi:10.1056/evidpha2600007
BibTeX
@article{Liu2026,
author = {Liu, Jiaojiao and Li, Shuk Hang and Ye, Naiqing and Griffiths, Tachianna and Drapeau, Elizabeth M and Atkinson, Reilly K and Collman, Ronald G and Hensley, Scott E},
title = {Antibodies Elicited by the 2025–2026 Influenza Vaccine},
journal = {NEJM Evidence},
year = {2026},
volume = {5},
number = {4},
doi = {10.1056/evidpha2600007}
}
EUVIMED